38.6c New Delhi, India, Thursday, January 15, 2026
Top Stories Supreme Court
Political NEWS Legislative Corner Celebstreet International Videos
Subscribe Contact Us
close
Judiciary

Delhi High Court Dismisses Plea To Legalise Cannabis For Medical Use, Imposes Rs 10K Cost

By LawStreet News Network      29 July, 2019 11:38 AM      0 Comments
Delhi High Court Dismisses Plea To Legalise Cannabis For Medical Use, Imposes Rs 10K Cost

The Delhi High Court on July 26, 2019, dismissed with a cost of Rs 10,000 a petition seeking to legalise cannabis for medical purpose.

A Bench comprising of Chief Justice D.N. Patel and Justice C. Hari Shankar said there was no substance in the petition and it was not inclined to grant the prayer.

"It appears this petition is seeking direction to legalise cannabis for medical use. It can only be done by bringing proper enactment or amendment under the Narcotics Drugs and Psychotropic Substances (NDPS) Act, 1985. We are not inclined to grant the prayer," the Bench said.

Dismissing the petition, the court imposed a cost of Rs 10,000 on the petitioner Prashant Sharma and directed him to deposit the amount with the Delhi High Court Bar Association Library fund.

The petition sought direction to the authorities to allow medical use of cannabis and its allied products, frame a proper policy for it and make necessary amendments in the NDPS Act in this regard.

The plea, filed through advocates Pankaj Mehta and R K Mehta, said cannabis has been erroneously treated as a criminal justice issue instead of a public health issue and it is high time that these errors are corrected.

It said the ban on cannabis was imposed in India in 1985 and prior to this, it was used for both religious and medical purposes. It was being used from ancient times to cure diseases.

The petition said that 21 countries including the United States of America and Canada have legalised or decriminalised marijuana (cannabis) usage for medical or recreational usage.

It claimed that several medical researches show that there is strong evidence of medical benefits of cannabis or cannabinoids in cases of nausea and vomiting associated with cancer chemotherapy and spinal cord injury.



Share this article:

User Avatar
About:


Leave a feedback about this
TRENDING NEWS


TOP STORIES

indias-business-families-seek-regulatory-recognition-of-daughters-in-law-as-relatives-under-sebi-takeover-norms
Trending Business
India’s Business Families Seek Regulatory Recognition of Daughters-in-Law as ‘Relatives’ Under SEBI Takeover Norms

Indian business families urge SEBI to recognise daughters-in-law as relatives under takeover norms, citing succession planning, trusts, gender equality and compliance risks.

09 January, 2026 05:58 PM
sc-bail-for-accused-added-under-section-319-crpc-requires-strong-and-cogent-evidence-not-mere-probability-of-complicity
Trending Judiciary
SC: Bail for Accused Added Under Section 319 CrPC Requires Strong and Cogent Evidence, Not Mere Probability of Complicity [Read Order]

Supreme Court rules that bail for accused added under Section 319 CrPC requires strong and cogent evidence, not mere probability of complicity.

09 January, 2026 06:04 PM
pre-deposit-under-sarfaesi-act-must-be-made-before-drat-not-before-bank-kerala-hc
Trending Judiciary
Pre-deposit Under SARFAESI Act Must Be Made Before DRAT, Not Before Bank: Kerala HC [Read Judgment]

Kerala HC holds SARFAESI pre-deposit must be made before DRAT, not the bank, and writ petitions are not maintainable when a statutory appellate remedy exists.

09 January, 2026 07:08 PM
auction-authority-cannot-cancel-highest-bid-to-seek-better-price-in-fresh-auction-sc
Trending Judiciary
Auction Authority Cannot Cancel Highest Bid to Seek Better Price in Fresh Auction: SC [Read Judgment]

Supreme Court rules auction authorities cannot cancel a valid highest bid merely to seek higher prices in a fresh auction, calling such action arbitrary and illegal.

09 January, 2026 07:25 PM

ADVERTISEMENT


Join Group

Signup for Our Newsletter

Get Exclusive access to members only content by email